EED mutations in individuals with Cohen-Gibson syndrome cluster in WD40 domains 3 through 5 and are predicted to (1) abolish interaction with EZH2, (2) prevent histone methyltransferase activity, and (3) inhibit H3K27me3 peptide binding. The gene discussed is PRDM9; the disease is Cohen-Gibson syndrome.